Search

Your search keyword '"Cancer treatment -- Forecasts and trends"' showing total 459 results

Search Constraints

Start Over You searched for: Descriptor "Cancer treatment -- Forecasts and trends" Remove constraint Descriptor: "Cancer treatment -- Forecasts and trends"
459 results on '"Cancer treatment -- Forecasts and trends"'

Search Results

151. Global Blood and Bone Marrow Cancer Treatment Market Trends & Analysis During the Forecast Period, 2019-2027

152. Immuno-Oncology Diagnostics: The Race for Biomarkers Market to 2024

153. Worldwide Immuno-Oncology Diagnostics Markets to 2024: The Race for Biomarkers

154. Global Immuno-Oncology Diagnostics Market Forecasts 2020-2024

155. Global Immuno-Oncology Diagnostics Market Forecasts 2020-2024 - ResearchAndMarkets.com

156. Global Immuno-Oncology Diagnostics Market Forecasts 2020-2024

157. DRGT Announces First Subject Dosed in a Phase I Clinical Trial of DRGT 45, a Novel Formulation of Abiraterone Acetate for Prostate Cancer

158. US and European Interventional Oncology Devices Market Assessment for Breast Cancer During the Forecast Period, 2016-2020

159. Xenetic Biosciences, Inc. Provides Business Outlook

160. Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma

161. Cervical Cancer Treatment Market is predicted to exhibit 6.5% CAGR from 2019 to 2023 | Market Segments, Dynamics, Size,Top Key Players, Current Trends, Supply and Demand

162. Global Blood and Bone Marrow Cancer Treatment Market to 2027 by Indication, Therapy, Geography, Competitive Landscape - ResearchAndMarkets.com

163. $74.9 Bn Blood and Bone Marrow Cancer Treatment Market, 2027

164. United States Breast Cancer Market and Competitive Landscape 2014-2019 & 2024

165. Global Blood and Bone Marrow Cancer Treatment Market to 2027 by Indication, Therapy, Geography, Competitive Landscape

166. Global Blood and Bone Marrow Cancer Treatment Market to 2027 by Indication, Therapy, Geography, Competitive Landscape - ResearchAndMarkets.com

167. Global Blood and Bone Marrow Cancer Treatment Market to 2027 by Indication, Therapy, Geography, Competitive Landscape

168. Ruth Bader Ginsburg makes first public appearance since completing cancer treatment

169. Rising Application of Systematic Therapeutics Delivery Systems to Accelerate the Growth of Global Radiation Therapy Market - TMR

170. Rising Application of Systematic Therapeutics Delivery Systems to Accelerate the Growth of Global Radiation Therapy Market - TMR

171. The United States Basal Cell Carcinoma Market & Competitive Landscape: 2014-2019 & 2024

172. Squamous Cell Carcinoma in the United States, 2019: The Market & Competitive Landscape, 2014 to 2024

173. Squamous Cell Carcinoma in the United States, 2019: The Market & Competitive Landscape, 2014 to 2024 - ResearchAndMarkets.com

174. The United States Basal Cell Carcinoma Market & Competitive Landscape: 2014-2019 & 2024 - ResearchAndMarkets.com

175. Squamous Cell Carcinomain the United States, 2019: The Market & Competitive Landscape, 2014 to 2024

176. The United States Basal Cell Carcinoma Market & Competitive Landscape: 2014-2019 & 2024

177. Global Novel Immuno-Oncology Biomarker Testing Market Report, 2019-2030 - Focus on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)

178. Global Novel Immuno-Oncology Biomarker Testing Market Report, 2019-2030 - Focus on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+) - ResearchAndMarkets.com

179. Novel Immuno-Oncology Biomarker Testing Market, 2019-2030

180. Embolization Particle Market Share Is Expected To Reach USD 1.9 Billion With a Lucrative CAGR of 9.6% Owing To Rising Usage Of Embolization Particle In Treatment Of Cancer Till 2023

181. United States Renal Cell Carcinoma Market & Competitive Landscape Analysis (2014-2024)

182. United States Renal Cell Carcinoma Market & Competitive Landscape Analysis (2014-2024) - ResearchAndMarkets.com

183. United States Renal Cell Carcinoma Market & Competitive Landscape Analysis (2014-2024)

184. Image Guided Radiotherapy Market to Boost at a CAGR of 15.8% Due to Rapid Development in Cancer Treatment During 2019-2023, Asserts MRFR

185. US Lung Cancer Market and Competitive Landscape - 2019

186. US Lung Cancer Market and Competitive Landscape - 2019 - ResearchAndMarkets.com

187. US Lung Cancer Market and Competitive Landscape - 2019

188. US Stomach Cancer Market and Competitive Landscape For 2019

189. US Bladder Cancer Market and Competitive Landscape, 2019

190. US Liver Cancer Hepatoma Market and Competitive Landscape During 2019

191. US Brain Cancer Market and Competitive Landscape Highlights, 2019

192. US Liver Cancer Hepatoma Market and Competitive Landscape During 2019 - ResearchAndMarkets.com

193. US Bladder Cancer Market and Competitive Landscape, 2019

194. US Stomach Cancer Market and Competitive Landscape For 2019

195. US Bladder Cancer Market and Competitive Landscape, 2019 - ResearchAndMarkets.com

196. US Stomach Cancer Market and Competitive Landscape For 2019 - ResearchAndMarkets.com

197. United States Ovarian Cancer Market and Competitive Landscape 2014-2018 & 2019-2024

198. United States Chronic Myeloid Leukemia Market and Competitive Landscape 2019-2024

199. United States Thyroid Cancer Market and Competitive Landscape 2019: Treatment Options, Pipeline Products, Epidemiology, Key Products Marketed, Market Valuations & Forecast, and Sales & Market Shares

200. US Brain Cancer Market and Competitive Landscape Highlights, 2019 - ResearchAndMarkets.com

Catalog

Books, media, physical & digital resources